# FDA recall D-1056-2019

> **Allergan Sales, LLC** · Class II · drug recall initiated 2019-03-19.

## Product

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only,  Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05

## Reason for recall

cGMP Deviations

## Distribution

TN only

## Key facts

- **Recall number:** D-1056-2019
- **Recalling firm:** Allergan Sales, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-03-19
- **Report date:** 2019-04-03
- **Termination date:** 2020-04-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Waco, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1056-2019

## Citation

> AI Analytics. FDA recall D-1056-2019. Retrieved 2026-07-18 from https://api.ai-analytics.org/recall/D-1056-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*